Quick Takeaways
- This page summarizes Halley E. Gilbert's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 03 Jun 2022, 16:56.
Halley E. Gilbert - 01 Jun 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)
- Role
- Director
- Signature
- /s/ Scott Burrows, as Attorney-in-Fact for Halley E. Gilbert
- Issuer symbol
- ARQT
- Transactions as of
- 01 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 03 Jun 2022, 16:56:16 UTC
- Previous filing
- 03 Mar 2022
- Next filing
- 17 Jun 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Halley E. Gilbert filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 03 Jun 2022."
What Changed
- Previous filing in this sequence was filed on 03 Mar 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARQT | Common Stock | Award | $0 | +4,312 | $0.000000 | 4,312 | 01 Jun 2022 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARQT | Stock Option (Right to Buy) | Award | $0 | +11,796 | $0.000000 | 11,796 | 01 Jun 2022 | Common Stock | 11,796 | $20.29 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. |
| F2 | The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. |